AQST Q4 2021 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$431M

Q4 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$11M+55.0% YoY

Gross Profit

$8M69.6% margin

Operating Income

-$12M-105.3% margin

Net Income

-$29M-261.3% margin

EPS (Diluted)

$-0.72

QoQ Revenue Growth

-16.6%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$9M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$62M

Total Liabilities

$144M

Stockholders' Equity

-$82M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$7M	+55.0%
Gross Profit	$8M	$4M	+76.8%
Operating Income	-$12M	-$16M	+25.4%
Net Income	-$29M	-$20M	-42.1%

Revenue Segments

Manufacture and Supply Revenue

$8M69%

Proprietary Product Sales

$3M25%

License and Royalty Revenue

$380,0003%

Co-Development and Research Fees

$218,0002%

Geographic Segments

UNITED STATES

$9M85%

Non-US

$2M15%